AIM
DNMR

Aigen Investment Management’s Danimer Scientific, Inc. DNMR Stock Holding History

Aigen Investment Management’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-730
Closed -$301K – 1177
2021
Q4 		$301K Buy
+730
New +$402K 0.02% 799

Other funds holding DNMR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TA
Teramo Advisors Naples, Florida $529M AUM 20.59% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Aigen Investment Management's DNMR Position: Q1 2022 in Review

Aigen Investment Management sold out of Danimer Scientific, Inc. (DNMR) in Q1 2022, closing a stake of 730 shares — an estimated $301K sold.

Aigen Investment Management first reported a position in DNMR in Q4 2021 and held it in 1 quarter. The position peaked at $301K in Q4 2021. 196 funds tracked by Wall St. Rank hold DNMR as of Q1 2022.

  • Aigen Investment Management reported no remaining Danimer Scientific, Inc. position as of Q1 2022 after selling out during the quarter.
  • Aigen Investment Management sold 730 Danimer Scientific, Inc. shares in Q1 2022, an estimated $301K.
  • Aigen Investment Management first reported a position in Danimer Scientific, Inc. in Q4 2021 and held it in 1 quarter.
  • Aigen Investment Management's Danimer Scientific, Inc. position peaked at $301K in Q4 2021.
  • 196 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q1 2022.

Based on Aigen Investment Management's 13F filing for Q1 2022, filed 5 May 2022.